Nicoderm Cq

   
Google
 
Web NewDrugInformation.com

Nicoderm Cq


Drug - Nicoderm Cq
The trade name of the product as shown on the labeling.

Dosage - FILM, EXTENDED RELEASE; TRANSDERMAL
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Nicotine
Multiple ingredients are in alphabetical order.

Strength - 21MG/24HR
The potency of the active ingredient(s), Nicotine. May repeat for multiple part products.

Applicant - AVENTIS PHARMS
The firm name holding legal responsibility for Nicoderm Cq. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 020165
The FDA assigned number to Nicoderm Cq. Format is nnnnnn.

Product Number - 004
The FDA assigned number to identify Nicoderm Cq. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Aug 2, 1996
The date Nicoderm Cq was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - Yes
The pioneer or innovator of Nicoderm Cq. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - OTC
The group or category of approved drugs Nicoderm Cq is in. Format is RX, OTC, DISCN.

Applicant Full Name - Aventis Pharmaceuticals Inc
The full name of the firm holding legal responsibility for the new application of Nicoderm Cq.

Nicoderm Cq